Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
BPC-157 has shown remarkable results in accelerating healing of tendon-to-bone injuries, ligament damage, and muscle tears in both preclinical studies and clinical experience
Common menstrual changes reported Women taking Mounjaro report several types of menstrual changes, with some patterns emerging from online communities and clinical observations: Heavier and more painful periods This appears to be the most commonly reported change
Moreover, it remains active in the body, helping regulate appetite and blood sugar levels throughout the day
If you have severe or intolerable heartburn, consult your doctor
Diet and lifestyle while on Strive tirzepatide Tirzepatide is not a magic shot